Early Outcomes From the English National Health Service Diabetes Prevention Programme
- PMID: 31719054
- PMCID: PMC7115827
- DOI: 10.2337/dc19-1425
Early Outcomes From the English National Health Service Diabetes Prevention Programme
Abstract
Objective: To assess weight and HbA1c changes in the Healthier You: National Health Service Diabetes Prevention Programme (NHS DPP), the largest DPP globally to achieve universal population coverage.
Research design and methods: A service evaluation assessed intervention effectiveness for adults with nondiabetic hyperglycemia (HbA1c 42-47 mmol/mol [6.0-6.4%] or fasting plasma glucose 5.5-6.9 mmol/L) between program launch in June 2016 and December 2018, using prospectively collected, national service-level data in England.
Results: By December 2018, 324,699 people had been referred, 152,294 had attended the initial assessment, and 96,442 had attended at least 1 of 13 group-based intervention sessions. Allowing sufficient time to elapse, 53% attended an initial assessment, 36% attended at least one group-based session, and 19% completed the intervention (attended >60% of sessions). Of the 32,665 who attended at least one intervention session and had sufficient time to finish, 17,252 (53%) completed: intention-to-treat analyses demonstrated a mean weight loss of 2.3 kg (95% CI 2.2, 2.3) and an HbA1c reduction of 1.26 mmol/mol (1.20, 1.31) (0.12% [0.11, 0.12]); completer analysis demonstrated a mean weight loss of 3.3 kg (3.2, 3.4) and an HbA1c reduction of 2.04 mmol/mol (1.96, 2.12) (0.19% [0.18, 0.19]). Younger age, female sex, Asian and black ethnicity, lower socioeconomic status, and normal baseline BMI were associated with less weight loss. Older age, female sex, black ethnicity, lower socioeconomic status, and baseline overweight and obesity were associated with a smaller HbA1c reduction.
Conclusions: Reductions in weight and HbA1c compare favorably with those reported in recent meta-analyses of pragmatic studies and suggest likely future reductions in participant type 2 diabetes incidence.
© 2019 by the American Diabetes Association.
Conflict of interest statement
All authors have completed the ICMJE uniform disclosure form and declare: JV is the National Clinical Director for Diabetes and Obesity at NHS England and is the Clinical Lead for the Healthier You: NHS Diabetes Prevention Programme. EB is the Head of Health Intelligence (diabetes) for Public Health England and leads analysis of the Diabetes Prevention Programme. DB is an analyst for NHS England and is actively involved in analysis of the programme. JF was the diabetes evidence and evaluation lead at Public Health England until September 2018. CB is the Primary Care Advisor to the NHS Diabetes Programme. BY is Clinical Lead of the National Diabetes Audit for England and Wales and a Trustee of Diabetes UK. KK was Chair of the Programme Development Group for the National Institute for Health and Care Excellence (NICE) public health guidance on Type 2 diabetes: prevention in people at high risk (NICE PH38). KK is also Co-Director of the Leicester Diabetes Centre (LDC), and one of the Programme Providers, Ingeus UK Ltd, provide interventions based on the type 2 diabetes prevention programme developed by LDC. NW was Chair of the Programme Development Group for NICE public health guidance on Type 2 diabetes prevention: population and community-level interventions (NICE PH35). JS represents Public Health England on the NHS England Diabetes Programme Board. SON is the Clinical Director at Diabetes UK.
KK acknowledges support from National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East Midlands and the NIHR Leicester BRC. SJ is funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre and Oxford NIHR Collaboration and Leadership in Applied Health Research.
Figures


References
-
- Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of Type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–1350. - PubMed
-
- Public Health England. A systematic review and meta-analysis assessing the effectiveness of pragmatic lifestyle interventions for the prevention of Type 2 diabetes mellitus in routine practice. [Accessed 18th May 2019]; Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploa....
-
- Dunkley AJ, Bodicoat DH, Greaves CJ, et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guidelines recommendations: a systematic review and meta-analysis. Diabetes Care. 2014;37(4):922–33. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous